BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8805302)

  • 1. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
    Lewis JW; Neisig A; Neefjes J; Elliott T
    Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the mutant HLA-A*0201 heavy chain H74L: impaired TAP-dependent peptide loading.
    Caley RR; Peace-Brewer AL; Matsui M; Frelinger JA
    Hum Immunol; 1999 Sep; 60(9):743-54. PubMed ID: 10527381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
    Knittler MR; Alberts P; Deverson EV; Howard JC
    Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains.
    Suh WK; Mitchell EK; Yang Y; Peterson PA; Waneck GL; Williams DB
    J Exp Med; 1996 Aug; 184(2):337-48. PubMed ID: 8760787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of peptide binding by MHC class I molecules on their interaction with TAP.
    Grandea AG; Androlewicz MJ; Athwal RS; Geraghty DE; Spies T
    Science; 1995 Oct; 270(5233):105-8. PubMed ID: 7569935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.
    Paulsson KM; Wang P; Anderson PO; Chen S; Pettersson RF; Li S
    Int Immunol; 2001 Aug; 13(8):1063-73. PubMed ID: 11470776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
    Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.
    Pentcheva T; Edidin M
    J Immunol; 2001 Jun; 166(11):6625-32. PubMed ID: 11359816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased efficiency of folding and peptide loading of mutant MHC class I molecules.
    Beissbarth T; Sun J; Kavathas PB; Ortmann B
    Eur J Immunol; 2000 Apr; 30(4):1203-13. PubMed ID: 10760810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells.
    Lauvau G; Gubler B; Cohen H; Daniel S; Caillat-Zucman S; van Endert PM
    J Biol Chem; 1999 Oct; 274(44):31349-58. PubMed ID: 10531335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.
    Tan P; Kropshofer H; Mandelboim O; Bulbuc N; Hämmerling GJ; Momburg F
    J Immunol; 2002 Feb; 168(4):1950-60. PubMed ID: 11823531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for successive peptide binding and quality control stages during MHC class I assembly.
    Lewis JW; Elliott T
    Curr Biol; 1998 Jun; 8(12):717-20. PubMed ID: 9637925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of the transport complex TAP in cellular immune recognition.
    Abele R; Tampé R
    Biochim Biophys Acta; 1999 Dec; 1461(2):405-19. PubMed ID: 10581370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-regulated peptide transfer from the transporter associated with antigen processing to major histocompatibility complex class I molecules by protein disulfide isomerase.
    Cho K; Cho S; Lee SO; Oh C; Kang K; Ryoo J; Lee S; Kang S; Ahn K
    Antioxid Redox Signal; 2011 Aug; 15(3):621-33. PubMed ID: 21299467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide selection by MHC-encoded TAP transporters.
    Momburg F; Neefjes JJ; Hämmerling GJ
    Curr Opin Immunol; 1994 Feb; 6(1):32-7. PubMed ID: 8172678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.
    Peace-Brewer AL; Tussey LG; Matsui M; Li G; Quinn DG; Frelinger JA
    Immunity; 1996 May; 4(5):505-14. PubMed ID: 8630735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.